Fred Rockwell

Connecting #smallcap and #microcap #companies with #investors and providing content for the entire #investment community.
Register:

[Fred Rockwell @FredRockIS]

Investor Summit Q3 2022 Virtual Conference Aug 16-17. 75 Microcap and Small Cap companies. 200+ investors, 1-on-1 meetings and more. Register today: https://t.co/fvjfWlepty
#microcaps #investing #conference

[Fred Rockwell @FredRockIS]

Link to the on-demand webcast for RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company --

https://t.co/E31HLhGsHZ

[Fred Rockwell @FredRockIS]

RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company
Their primary mission is to develop innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling.
Presenters: Jeff Margolis, Arnold Lippa
Market cap: $1 million

[Fred Rockwell @FredRockIS]

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

[Fred Rockwell @FredRockIS]

Highlights:
-- Potential breakthrough products for treating disorders with unmet medical needs
-- Broad and deep patent portfolio

#investorsummit #q4 #respirerxpharmaceuticals #biotech #conference #invest

[Fred Rockwell @FredRockIS]

Link to the on-demand webcast Predictive Oncology Inc : https://t.co/u6F2kkfISR

[Fred Rockwell @FredRockIS]

@PredictiveOnc (NASDAQ: POAI) creates a paradigm shift in drug development. Their flagship solution pairs proprietary AI w world’s largest commercial biobank of more than 150,000 tumor samples covering more than 130 cancer types & has power to advance the making of cancer drugs.

[Fred Rockwell @FredRockIS]

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

[Fred Rockwell @FredRockIS]

--With a 92% accuracy, PeDAL is validated to predict with higher confidence whether a cancer tumor sample will respond
--They offer the ability to test the viability of a cell with its 3D tumor models.

[Fred Rockwell @FredRockIS]

Link to the on-demand webcast for @CingulateInc : https://t.co/lvI3Sbwtvw

#cingulate #investorsummit #q4 #biotech #biotechcompany #investing

[Fred Rockwell @FredRockIS]

@CingulateInc (NASDAQ: CING), is a biopharmaceutical company using proprietary PTR™ drug delivery platform technology to build & advance pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions

[Fred Rockwell @FredRockIS]

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

[Fred Rockwell @FredRockIS]

Presenters: Thomas Dalton
Market cap: $13 million

Highlights:
- Using approved molecules, they can achieve the first true full active day dosing for ADHD
- Their proprietary drug delivery technology applies 2 numerous large markets with suboptimal medication dosing delivery

[Fred Rockwell @FredRockIS]

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

[Fred Rockwell @FredRockIS]

as well as Alzheimer's, and Lou Gehrig's disease.

Link to on-demand broadcast:
https://t.co/YgZZ1yULhL

#investorsummit #biotech #biotechcompanies #q4

[Fred Rockwell @FredRockIS]

Highlights:
-Revenue from near-term sales of generic drugs & an in vitro diagnostic, w longer-term potential from a patented, alpha-Klotho gene therapy program.
-Essential, life-saving medicines that are in short supply/are in development for use to treat diseases like cancer

[Fred Rockwell @FredRockIS]

ANEW MEDICAL, INC. (ANEW)
It's a publicly listed biotechnology company committed to the development of diagnostics and therapies for the benefit of the world’s elderly population and the multiple age-related disorders from which they suffer.

Market cap: $2 million

[Fred Rockwell @FredRockIS]

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

[Fred Rockwell @FredRockIS]

#investorsummit #biotech #biotechconpanies #q4

[Fred Rockwell @FredRockIS]

Predictive Oncology Inc. (NASDAQ: POAI) is creating a paradigm shift in drug development. The company’s flagship solution pairs proprietary AI with the world’s largest commercial biobank of more than 150,000 actual tumor samples covering more than 130 cancer types

[Fred Rockwell @FredRockIS]

Direct link to on-demand webcast: https://t.co/lvI3Sbfqtw